293 related articles for article (PubMed ID: 25466924)
21. Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry.
La Monica G; Bono A; Alamia F; Lauria A; Martorana A
Bioorg Med Chem; 2024 Jul; 109():117791. PubMed ID: 38870715
[TBL] [Abstract][Full Text] [Related]
22. The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review.
Shiro T; Fukaya T; Tobe M
Eur J Med Chem; 2015 Jun; 97():397-408. PubMed ID: 25532473
[TBL] [Abstract][Full Text] [Related]
23. Advancement in chiral heterocycles for the antidiabetic activity.
Gupta T; Rani D; Nainwal LM; Badhwar R
Chirality; 2024 Feb; 36(2):e23637. PubMed ID: 38384150
[TBL] [Abstract][Full Text] [Related]
24. Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles.
Burgeson JR; Moore AL; Gharaibeh DN; Larson RA; Cerruti NR; Amberg SM; Hruby DE; Dai D
Bioorg Med Chem Lett; 2013 Feb; 23(3):750-6. PubMed ID: 23265900
[TBL] [Abstract][Full Text] [Related]
25. Copper-catalyzed trifluoromethylation of internal olefinic C-H bonds: efficient routes to trifluoromethylated tetrasubstituted olefins and N-heterocycles.
Mao Z; Huang F; Yu H; Chen J; Yu Z; Xu Z
Chemistry; 2014 Mar; 20(12):3439-45. PubMed ID: 24677229
[TBL] [Abstract][Full Text] [Related]
26. Naturally Occurring O-Heterocycles as Anticancer Agents.
Avula SK; Das B; Csuk R; Al-Harrasi A
Anticancer Agents Med Chem; 2022; 22(19):3208-3218. PubMed ID: 34749628
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive experimental study of N-heterocyclic π-stacking interactions of neutral and cationic pyridines.
Li P; Zhao C; Smith MD; Shimizu KD
J Org Chem; 2013 Jun; 78(11):5303-13. PubMed ID: 23675885
[TBL] [Abstract][Full Text] [Related]
28. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
[TBL] [Abstract][Full Text] [Related]
29. Heterocycles: Versatile control elements in bioactive macrocycles.
Soor HS; Appavoo SD; Yudin AK
Bioorg Med Chem; 2018 Jun; 26(10):2774-2779. PubMed ID: 29735427
[TBL] [Abstract][Full Text] [Related]
30. Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.
Lang DK; Kaur R; Arora R; Saini B; Arora S
Anticancer Agents Med Chem; 2020; 20(18):2150-2168. PubMed ID: 32628593
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of a novel class of CK2 inhibitors: application of copper- and gold-catalysed cascade reactions for fused nitrogen heterocycles.
Suzuki Y; Oishi S; Takei Y; Yasue M; Misu R; Naoe S; Hou Z; Kure T; Nakanishi I; Ohno H; Hirasawa A; Tsujimoto G; Fujii N
Org Biomol Chem; 2012 Jul; 10(25):4907-15. PubMed ID: 22610034
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals.
Vitaku E; Smith DT; Njardarson JT
J Med Chem; 2014 Dec; 57(24):10257-74. PubMed ID: 25255204
[TBL] [Abstract][Full Text] [Related]
33. Furans, thiophenes and related heterocycles in drug discovery.
Sperry JB; Wright DL
Curr Opin Drug Discov Devel; 2005 Nov; 8(6):723-40. PubMed ID: 16312148
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antioxidant activity of a new class of bis and tris heterocycles.
Padmavathi V; Venkatesh BC; Muralikrishna A; Padmaja A
Arch Pharm (Weinheim); 2012 Sep; 345(9):745-52. PubMed ID: 22592954
[TBL] [Abstract][Full Text] [Related]
35. Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.
Valentina P; Ilango K; Kathiravan MK
Arch Pharm Res; 2016 Oct; 39(10):1382-1390. PubMed ID: 27469336
[TBL] [Abstract][Full Text] [Related]
36. Autophagy-regulating N-heterocycles derivatives as potential anticancer agents.
Liang X; Zhang L; Li F; Luan S; He C; Yin L; Yin Z; Zou Y; Yue G; Li L; Song X; Lv C; Zhang W; Jing B
Future Med Chem; 2020 Feb; 12(3):223-242. PubMed ID: 31823643
[TBL] [Abstract][Full Text] [Related]
37. Direct sp3 C-H bond activation adjacent to nitrogen in heterocycles.
Campos KR
Chem Soc Rev; 2007 Jul; 36(7):1069-84. PubMed ID: 17576475
[TBL] [Abstract][Full Text] [Related]
38. Construction of nitrogen-containing heterocycles by C-H bond functionalization.
Thansandote P; Lautens M
Chemistry; 2009 Jun; 15(24):5874-83. PubMed ID: 19440997
[TBL] [Abstract][Full Text] [Related]
39. 5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.
Ivachtchenko AV; Ivanenkov YA; Skorenko AV
Expert Opin Ther Pat; 2012 Oct; 22(10):1123-68. PubMed ID: 22957857
[TBL] [Abstract][Full Text] [Related]
40. Molecular Modeling Studies on Some Important Anticancer Heterocycles: An Overview.
Kale M; Sonwane G; Nawale R; Mourya V
Curr Comput Aided Drug Des; 2018; 14(3):178-190. PubMed ID: 29564984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
